Literature DB >> 11926322

Northwestern University Auditory Test No. 6 in multi-talker babble: a preliminary report.

Richard H Wilson1, Anne Strouse.   

Abstract

The purpose of this project was to develop a spoken word-recognition task that could be used clinically to evaluate recognition performance of individuals with hearing loss in a background noise. The test instrument incorporated monosyllabic words at seven levels over a 35-dB range presented in a background of "multi-talker" babble that was fixed in level. In Experiment 1, we established normative data on 24 young adult listeners with normal hearing and on 50 older adult listeners with high-frequency hearing loss. In Experiment 2, we examined the effects that age and hearing loss have on understanding speech in multi-talker babble by studying 15 subjects in each decade interval from 20 to 79 years.

Entities:  

Mesh:

Year:  2002        PMID: 11926322

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  4 in total

1.  Multisensory and modality specific processing of visual speech in different regions of the premotor cortex.

Authors:  Daniel E Callan; Jeffery A Jones; Akiko Callan
Journal:  Front Psychol       Date:  2014-05-05

Review 2.  Variations in the slope of the psychometric functions for speech intelligibility: a systematic survey.

Authors:  Alexandra MacPherson; Michael A Akeroyd
Journal:  Trends Hear       Date:  2014-06-06       Impact factor: 3.293

3.  Complex Acoustic Environments: Review, Framework, and Subjective Model.

Authors:  Adam Weisser; Jörg M Buchholz; Gitte Keidser
Journal:  Trends Hear       Date:  2019 Jan-Dec       Impact factor: 3.293

4.  Hearing in middle age: a population snapshot of 40- to 69-year olds in the United Kingdom.

Authors:  Piers Dawes; Heather Fortnum; David R Moore; Richard Emsley; Paul Norman; Karen Cruickshanks; Adrian Davis; Mark Edmondson-Jones; Abby McCormack; Mark Lutman; Kevin Munro
Journal:  Ear Hear       Date:  2014 May-Jun       Impact factor: 3.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.